ABCL

#2044
AbCellera Biologics Inc. Common Shares
3.61
+3.74%
Sector:
Básica:
Profit Currency:
Rango diario
3.61
3.61
Rango anual
1.89
6.52
Cambio diario
+3.74%
Monthly Change
-10.86%
6 month change
-18.51%
Cambio anual
+32.72%
Cierres anteriores
3.48
Open
3.61
Bid
Ask
Low
3.61
High
3.61
Volumen
47
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20212022202320242025 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Noticias